Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Apr 3, 2017
Insider Transaction Report
Form 4
Cartt Stephen LaHue
DirectorPresident and CEO
Transactions
- Award
Common Stock
2017-03-30+32,783→ 292,783 total - Award
Stock Options
2017-03-30+200,000→ 200,000 totalExercise: $3.45From: 2017-03-30Exp: 2027-03-29→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The stock options reported herein vest as follows: one quarter of the options vest upon on the one year anniversary of the date of grant, and the remaining options vest in 36 equal monthly installments thereafter.